5Prisco D. Acquired hemophilia A: a rare but important challenge for the internist[J]. Ann Ital Med Int, 2005, 20 (3) :4-5.
6Theodossiades G, Kontopoulou Griva I. Acquired hemophilia A [ J ]. Haematology, 2002, 5 (4) : 282-290.
7Lindgren A, Wadenvik H, Tengbom L. Characterization of inhibitors to FVⅧ with an ELISA in congenital and acquired haemophilia A [J ]. Haemophilia, 2002, 8 (5) :644-648.
6Wolfhart K, Carmen EE, Inmaculada MS, et al. Epide miology of inhibitor development in haemopidia A patient treated with virus - inactived plasma derived cloting factor concentrates. Vox Song, 1999, 77(Suppl):3.
7Knobl P, Defiler K, Komingex L, et al. Elimination of acquixtd factor Ⅲ antibodies by extracorporal antibody- based immamosdsorption(Ig- Theaasorb).Thromb Haemst, 1995, 74(4) : 1035.
8Monism AE, Ludlam CA, Kessler C. Use of Ixrcine factor Ⅲ in the treetment of patients with acquired hernqphilia. Blood, 1993, 81(6):1513.
9Owen CK. The diagnosis of bleeding disorders. 2 ed. Boston: Brorm and Company, 1975. 338- 344.
10Takahashi Y, Arai M, Fakutake K. Analysis of factxas which affect the measurrement of facttor Ⅷ inhibitor by Bethesda method. R linshobyofi, 1996, 44.(5):449.
